000 03681nam a22005655i 4500
001 978-3-642-25605-9
003 DE-He213
005 20140220083306.0
007 cr nn 008mamaa
008 120827s2012 gw | s |||| 0|eng d
020 _a9783642256059
_9978-3-642-25605-9
024 7 _a10.1007/978-3-642-25605-9
_2doi
050 4 _aR895-920
072 7 _aMMPH
_2bicssc
072 7 _aMMP
_2bicssc
072 7 _aMED008000
_2bisacsh
082 0 4 _a616.0757
_223
100 1 _aLo, Simon S.
_eeditor.
245 1 0 _aStereotactic Body Radiation Therapy
_h[electronic resource] /
_cedited by Simon S. Lo, Bin S. Teh, Jiade J. Lu, Tracey E. Schefter.
264 1 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2012.
300 _aXXV, 421 p. 120 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aMedical Radiology,
_x0942-5373
505 0 _aIntroduction -- Safety and Quality Assurance -- CyberKnife system -- Novalis system -- HiART TomoTherapy system -- Treatment planning -- AAPM recommendation --  Launching a stereotactic body radiation therapy program -- Radiobiology of stereotactic body radiation therapy -- Primary Lung Cancer -- Primary Liver Cancer -- Prostate Cancer -- Cell Carcinoma -- Gynecologic Cancer -- Pancreatic Cancer -- Benign and Malignant Primary Spinal Tumors -- Non-Skull Base Head and Neck Cancer -- Skull Base Head and Neck Cancer -- Lung  Metastasis -- Liver Metastasis -- Adrenal Metastasis -- Histologic Specific Metastasis -- Bone Metastasis -- Spinal Metastasis -- Reported toxicities associated with stereotactic body radiation therapy -- Normal tissue constraints.-Conduction of Trials in Stereotactic Body Radiation Therapy.
520 _aStereotactic body radiation therapy (SBRT) has emerged as an innovative treatment for various primary and metastatic cancers, and the past five years have witnessed a quantum leap in its use. This book provides a comprehensive and up-to-date account of the physical/technological, biological, and clinical aspects of SBRT. It will serve as a detailed resource for this rapidly developing treatment modality. The organ sites covered include lung, liver, spine, pancreas, prostate, adrenal, head and neck, and female reproductive tract. Retrospective studies and prospective clinical trials on SBRT for various organ sites from around the world are examined, and toxicities and normal tissue constraints are discussed. This book features unique insights from world-renowned experts in SBRT from North America, Asia, and Europe. It will be necessary reading for radiation oncologists, radiation oncology residents and fellows, medical physicists, medical physics residents, medical oncologists, surgical oncologists, and cancer scientists.
650 0 _aMedicine.
650 0 _aRadiology, Medical.
650 0 _aRadiotherapy.
650 0 _aOncology.
650 0 _aCancer
_xSurgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aImaging / Radiology.
650 2 4 _aDiagnostic Radiology.
650 2 4 _aRadiotherapy.
650 2 4 _aOncology.
650 2 4 _aSurgical Oncology.
700 1 _aTeh, Bin S.
_eeditor.
700 1 _aLu, Jiade J.
_eeditor.
700 1 _aSchefter, Tracey E.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783642256042
830 0 _aMedical Radiology,
_x0942-5373
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-25605-9
912 _aZDB-2-SME
999 _c102450
_d102450